Benzoic acid, 4-methyl-, [3-(4-methylbenzoyloxy)-5-methylphenyl] ester

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 缩酚酸和缩酚酸环醚类
• 英文名称: Benzoic acid, 4-methyl-, [3-(4-methylbenzoyloxy)-5-methylphenyl] ester
• 英文别名: [3-methyl-5-(4-methylbenzoyl)oxyphenyl] 4-methylbenzoate
• 化学式: C₂₃H₂₀O₄
• mdl: MFCD00227278
• 分子量: 360.4
• InChiKey: WBGSVIQPKHPTKX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• BETA-2-ADRENORECEPTOR AGONISTS
  申请人：Cuenoud Bernard

  公开号：US20100029705A1

  公开（公告）日：2010-02-04

  Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.

  该化合物的化学式为自由或盐或溶剂形式，其中Ar是化学式的一组，Y是碳或氮，R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、X、n、p、q和r的定义在说明书中，其制备以及其作为药物的用途，特别是用于治疗阻塞性或炎症性呼吸道疾病。
• Beta-2-Adrenoreceptor Agonists
  申请人：Cuenoud Bernard

  公开号：US20120077838A1

  公开（公告）日：2012-03-29

  Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.

  该化合物的化学式为自由或盐或溶剂形式，其中Ar是公式的一组，Y为碳或氮，R1，R2，R3，R4，R5，R6，R7，R8，R9，R10，X，n，p，q和r如规范所定义，它们的制备以及它们作为药物的用途，特别是用于治疗阻塞性或炎症性呼吸道疾病。
• beta-2-Adrenoreceptor Agonists
  申请人：Cuenoud Bernard

  公开号：US20120302531A1

  公开（公告）日：2012-11-29

  Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.

  该化合物的分子式可以是自由形式、盐形式或溶剂形式，其中Ar是化学式的一组，Y是碳或氮，而R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、X、n、p、q和r的定义在说明书中，其制备及其作为药物的用途，特别是用于治疗阻塞性或炎症性气道疾病。
• Beta2-Adrenoreceptor Agonists
  申请人：Cuenoud Bernard

  公开号：US20140066478A1

  公开（公告）日：2014-03-06

  Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways disease.

  该化合物的分子式为自由态、盐态或溶剂态，其中Ar为公式组，Y为碳或氮，R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、X、n、p、q和r的定义在规范中，其制备以及它们作为药物的用途，特别是用于治疗阻塞性或炎症性气道疾病。
• BETA2-ADRENORECEPTOR AGONISTS
  申请人：Cuenoud Bernard

  公开号：US20130231367A1

  公开（公告）日：2013-09-05

  Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , X, n, p, and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.

  该化合物的分子式为自由或盐或溶剂形式，其中Ar是公式的一组，Y是碳或氮，R1，R2，R3，R4，R5，R6，R7，R8，R9，R10，X，n，p和r如规范中定义，它们的制备及其用途作为药物，特别是用于治疗阻塞性或炎性呼吸道疾病。